Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Metabolism ; 50(11): 1361-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11699058

ABSTRACT

Analysis of sterol composition in serum, liver, adipose tissue, adrenals, and abdominal aorta demonstrated that the contents of plant sterols, campesterol and sitosterol, were evidently higher in WKY and stroke-prone spontaneously hypertensive (SHRSP) rats than in Wistar and WKA rats fed a diet containing a 0.5% plant sterol mixture. Lymphatic 24-hour recovery of 3H-sitosterol was about 2-fold higher in the WKY and SHRSP rats than in the WKA rats. Lymphatic absorption of 14C-cholesterol was also higher in WKY and SHRSP rats compared with WKA rats, but the difference was smaller than in the case of sitosterol. The remarkable increase of sitosterol absorption in WKY and SHRSP rats was observed between 9 and 24 hours after the administration. In SHRSP rats, lymphatic absorption of sitosterol between 0 and 3 hours was also higher than those in the other rat strains. Markedly less esterified 3H-sitosterol was detected in lymph than 14C-cholesterol in all strains, and in WKY and SHRSP rats, only a small increase in the esterified forms of sitosterol and cholesterol was observed. Although the incorporation of micellar 3H-sitosterol and 14C-cholesterol into intestinal brush border membranes was higher in SHRSP rats than in WKA rats, no difference was observed between WKY and WKA rats. These observations suggest that the incorporation into the brush border membranes and the esterification of sterols are not the major determinants for the hyperabsorption of sitosterol and cholesterol in SHRSP and WKY rats. Secretion of sitosterol and cholesterol in the bile of rats fed a plant sterol mixture was lower in SHRSP than in WKA rats. These results suggest that WKY and SHRSP strains deposit plant sterols in the body by enhancing the absorption and lowering the excretion of plant sterols. These strains of rats may be suitable models for studying mechanisms of differential absorption of various sterols.


Subject(s)
Cholesterol/analogs & derivatives , Cholesterol/metabolism , Phytosterols/metabolism , Sitosterols/metabolism , Adipose Tissue/metabolism , Adrenal Glands/metabolism , Animals , Aorta, Abdominal/metabolism , Bile/metabolism , Cholesterol/administration & dosage , Dietary Supplements , Genetic Predisposition to Disease , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/metabolism , Intestinal Mucosa/metabolism , Liver/metabolism , Lymphatic System/metabolism , Male , Microvilli/metabolism , Organ Specificity , Phytosterols/administration & dosage , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Rats, Wistar , Sitosterols/administration & dosage , Species Specificity , Stroke/genetics , Stroke/metabolism
2.
Comp Biochem Physiol B Biochem Mol Biol ; 120(3): 579-86, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9787818

ABSTRACT

Gemfibrozil is a widely used drug prescribed to elevate serum high-density lipoprotein (HDL) cholesterol levels and lower triacylglycerols. The present study was done to determine if the drug would alleviate hypercholesterolemia in exogenously hypercholesterolemic (ExHC) rats. In the drug-treated ExHC rats, the serum non-HDL cholesterol levels were lowered and the ratio of the non HDL cholesterol to serum triacylglycerols was decreased to the extent seen in the drug-treated SD rats. Liver cholesterol and triacylglycerols were lowered in the drug-treated rats. There was also an increase in fecal excretion of neutral sterols and bile acids, particularly chenodeoxycholic and beta-muricholic acids. The drug elevated cholesterol 7 alpha-hydroxylase activity and mRNA abundance and acyl-CoA cholesterol acyltransferase activity in the liver, but did not influence low-density lipoprotein receptor mRNA level in the liver. Thus, gemfibrozil is effective in alleviating hypercholesterolemia in exogenously hypercholesterolemic rats, by partitioning hepatic cholesterol into biliary excretion.


Subject(s)
Cholesterol/blood , Gemfibrozil/therapeutic use , Hypercholesterolemia/blood , Hypercholesterolemia/drug therapy , Hypolipidemic Agents/therapeutic use , Animals , Apolipoproteins/genetics , Apolipoproteins/metabolism , Cholesterol 7-alpha-Hydroxylase/genetics , Cholesterol 7-alpha-Hydroxylase/metabolism , Cholesterol, Dietary/administration & dosage , Feces/chemistry , Female , Hydroxymethylglutaryl CoA Reductases/genetics , Hydroxymethylglutaryl CoA Reductases/metabolism , Hypercholesterolemia/etiology , Lipid Metabolism , Liver/metabolism , Male , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sterol O-Acyltransferase/genetics , Sterol O-Acyltransferase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...